OK
Oklahoma House Bill HB1416

Oklahoma 2025 Regular Session

Oklahoma House Bill HB1416

Introduced
2/3/25  
Refer
2/4/25  
Refer
2/4/25  
Report Pass
2/26/25  
Engrossed
3/4/25  

Caption

Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Latest OK HB1416 Activity

View All Events: OK 2025 Regular Session HB1416

Companion Bills

No companion bills found.

Previously Filed As

OK HB3326

Narcotic treatment programs; opioid substitution treatment programs and compliance; modifying mandatory observance of drug abuse testing; effective date.

OK HB3013

Abortion-inducing drugs; defining terms; trafficking drugs; exceptions; felony; effective date.

OK HB2686

Substance abuse services; the Hannah McKenzie Act; opioid substitution treatment programs; federal requirements; requiring observed drug abuse testing; grounds for penalties; effective date; emergency.

OK HB2686

Substance abuse services; the Hannah McKenzie Act; opioid substitution treatment programs; federal requirements; requiring observed drug abuse testing; grounds for penalties; effective date; emergency.

OK SB146

Prescription drugs; creating the Access to Lifesaving Medicines Act. Effective date.

OK SB146

Prescription drugs; creating the Access to Lifesaving Medicines Act. Effective date.

OK SB768

Prescription drugs; establishing certain requirements relating to drug manufacturing and pricing. Effective date.

OK SB768

Prescription drugs; establishing certain requirements relating to drug manufacturing and pricing. Effective date.

OK HB2748

Public health and safety; step therapy requirements for certain drugs for certain conditions; definitions; authorizing a health benefit plan to allow coverage for prescription drugs for advanced metastatic cancer and associated conditions without proving step therapy; effective date.

OK HB2748

Public health and safety; step therapy requirements for certain drugs for certain conditions; definitions; authorizing a health benefit plan to allow coverage for prescription drugs for advanced metastatic cancer and associated conditions without proving step therapy; effective date.

Similar Bills

No similar bills found.